Search:

Product Information All Elsevier Sites   Advanced Product Search
SiteStat.jsp
HEPATIC FIBROSIS: PATHOGENESIS, DIAGNOSIS AND EMERGING THERAPIES, AN ISSUE OF CLINICS IN LIVER DISEASE, 12-4
Hepatic Fibrosis: Pathogenesis, Diagnosis and Emerging Therapies, An Issue of Clinics in Liver Disease, 12-4
To order this title, and for more information, click here

By
Scott Friedman

Included in series
The Clinics: Internal Medicine,

Description
Hepatic fibrosis is the final common pathway for a multitude of liver injuries. Viral-, immune-, or toxin-mediated liver injuries all result in expansion of the extracellular matrix with distortion of hepatic architecture and development of cirrhosis. Originally thought of as a one-way street, hepatic fibrosis now is recognized as a dynamic process with the potential for significant resolution. Authors in this issue address the genetic determinants of fibrosis, oxidant stress, cellular contractility and vasoregulation, as well as relationships between stellate cell activation, progenitor cells and hepatic regeneration. Current and future antifibrotic therapies are also discussed.

Bibliographic details
Hardbound, 240 pages, publication date: NOV-2008
ISBN-13: 978-1-4160-6315-5
ISBN-10: 1-4160-6315-3
Imprint: SAUNDERS


041/407
Last update: 10 Sep 2009
Reviews
Submit your review
Bookmark this page
Recommend this publication
Overview of all books
Printer-friendly version   Printer-friendly version